Covid-19 Science: Why does it spread so fast and why are obesity and age extra risks?

Worldwide more than 41 million people have now been infected with SARS-CoV-2 and over a million people have died. But what makes this virus so difficult to control, and why are some people more at risk than others? Elisabeth Mahase reports for the BMJ website. Why is it so hard to stop SARS-CoV-2 spreading? Paul Lehner, … Continue reading Covid-19 Science: Why does it spread so fast and why are obesity and age extra risks?

Encouraging Signs For Oxford Vaccine in Trials

The University of Oxford coronavirus vaccine that is currently being trialled has been found to produce an immune response in people over the age of 55. The results are encouraging because older people are at an increased risk of becoming severely ill and dying from covid-19, partly because the immune system weakens with age. The finding, which has not … Continue reading Encouraging Signs For Oxford Vaccine in Trials

Disability Right UK: New shielding guidance lacks basic protections

This article is from Disability Rights UK's website. The 2.2 million people advised to shield back in March have been advised by government to carry on with life, but at “one step beyond” their area’s current three-tier standing. The new guidance offers little in the way of support to those who previously shielded, such as … Continue reading Disability Right UK: New shielding guidance lacks basic protections

Long Covid – Latest interpretation of new syndrome

Long covid, the name commonly used to explain lasting effects of covid-19, may actually be four different syndromes, according to a review by the National Institute for Health Research (NIHR).1 A team of researchers and doctors reviewed current evidence and interviewed post-hospitalised and non-hospitalised patients and reported that long covid did not seem to fit … Continue reading Long Covid – Latest interpretation of new syndrome

Covid-19 Vaccine – Latest On Who Will Get It First

This is interim advice for the Government from the Joint Committee on Vaccination and Immunisation (JCVI) on the groups that should be prioritised for vaccination, if and when a vaccine is available. Introduction This update to the interim advice has been developed to facilitate planning for the deployment of any safe and effective vaccine(s) as … Continue reading Covid-19 Vaccine – Latest On Who Will Get It First